Table 6.
Association of dietary supplements, antibiotics, and comorbidities for the disease.
| a | LCL b | UCL c | aOR d | p-Value | |
|---|---|---|---|---|---|
| age | |||||
| 0–10 | Ref e | ||||
| 11–20 | 2003 | 2.0997 | 3.3290 | 2.6438 | 0.0000 |
| 21–30 | 3377 | 2.4145 | 3.7744 | 3.0189 | 0.0000 |
| 31–40 | 3412 | 2.1247 | 3.3040 | 2.6496 | 0.0000 |
| 41–50 | 3359 | 1.5622 | 2.4222 | 1.9453 | 0.0000 |
| 51–60 | 4011 | 1.0804 | 1.6695 | 1.3430 | 0.0079 |
| >70 | 2807 | 0.5097 | 0.7887 | 0.6341 | 0.0000 |
| Intercept | 1.8792 | 2.9404 | 2.3507 | 0.0000 | |
| Gender | |||||
| Male | Ref | ||||
| Female | 15,543 | 2.0153 | 2.1931 | 2.1024 | 0.0000 |
| Clarithromycin | 225 | 1.4559 | 2.1904 | 1.7857 | 0.0000 |
| Z_pak | 7592 | 1.5693 | 1.7137 | 1.6398 | 0.0000 |
| VitB6 | 54 | 1.0515 | 2.4383 | 1.6011 | 0.0283 |
| CoQ | 143 | 1.2244 | 1.8736 | 1.5145 | 0.0001 |
| BMI | |||||
| <18.5 | Ref | ||||
| 18.5–24.99 | 5473 | 0.5887 | 0.7924 | 0.6830 | 0.0000 |
| 25–29.99 | 5817 | 0.4823 | 0.6479 | 0.5590 | 0.0000 |
| 30–39.99 | 7352 | 0.4246 | 0.5702 | 0.4921 | 0.0000 |
| >=40 | 2892 | 0.4342 | 0.5913 | 0.5067 | 0.0000 |
| ElevatedESR | 99 | 0.4614 | 0.8791 | 0.6369 | 0.0061 |
| HeartFailure | 362 | 0.5487 | 0.7188 | 0.6280 | 0.0000 |
| CoronaryArteryDisease | 1171 | 0.4861 | 0.5663 | 0.5247 | 0.0000 |
| Osteoarthritis | 674 | 0.4119 | 0.5139 | 0.4601 | 0.0000 |
| ElevatedCRP | 73 | 0.1946 | 0.3936 | 0.2768 | 0.0000 |
| Obesity | 1986 | 0.2164 | 0.2501 | 0.2327 | 0.0000 |
| Hypertension | 8527 | 0.0987 | 0.1094 | 0.1039 | 0.0000 |
| InsulinDependentDiabetes | 126 | 0.0778 | 0.1216 | 0.0973 | 0.0000 |
a Number of patients with disease; b Lower Confidence Limit; c Upper Confidence Limit; d Adjusted Odds Ratio; e Reference level.